Goldman Sachs has commenced coverage of Guardant Health, assigning the stock a buy rating. This decision reflects the investment bank's positive outlook on the company's potential for growth in the healthcare sector. Investors may view this rating as a signal of confidence in Guardant Health's business model and future performance in the market.
Related Articles
Don't miss out on breaking stories and in-depth articles.